University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients ...

Thus, among the long-term hematopoietic stem cells (LTHSC) found in CML, the Mpl marker distinguishes a group that appears to be leukemic and a group that appears to be non-leukemic. Similar ...

Corresponding author of the study, Associate Professor Yukio Nakamura states, this study assessed the impacts of both PEN and CML on a number of bone turnover-related markers, BMD, and fractures ...

This has enabled the confident use of the Ph/BCR–ABL marker to specifically identify and quantify any CML patient's leukemic cells, regardless of the tissue from which they are obtained ...

Until the 1980s, CML was regarded as incurable and thus inexorably ... Although data on cytogenetic responses as a surrogate marker of survival suggest that imatinib prolongs the survival of ...

One is that CML is a stem cell disease, and like all stem cell diseases, you can often find the marker in other lineages. One thing I think you're doing, and the University of Adelaide has shown ...

Circular RNAs (circRNA) are potential diagnostic and prognostic markers, as well as therapeutic ... free survival after TKI discontinuation in CML patients who attain a sustained deep molecular ...

Chronic myelogenous leukemia (CML) is a cancer that affects your blood cells and bone marrow -- the soft part inside your bones where blood cells are made. You may also hear your doctor call it ...

Thus, among the long-term hematopoietic stem cells (LTHSC) found in CML, the Mpl marker distinguishes a group that appears to be leukemic and a group that appears to be non-leukemic. Similar ...